Article Text

Download PDFPDF
Atrial fibrillation
New treatment options for atrial fibrillation: towards patient tailored therapy

Statistics from


  • Competing interests In compliance with EBAC/EACCME guidelines, all authors participating in Education in Heart have disclosed potential conflicts of interest that might cause a bias in the article. Isabelle van Gelder has received consulting fees/honoraria from Medtronic, MSD, Sanofi-Aventis, Boehringer Ingelheim, and Aga medical, and research grants from the Netherlands Heart Foundation, the Interuniversity Cardiology Institute the Netherlands, and from Astra Zeneca, Biotronik, Medtronic, Sanofi-Aventis, Boehringer Ingelheim, St Jude Medical, and Boston Scientific.

  • Provenance and peer review Commissioned; internally peer reviewed

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.